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The NS3 protein of the tenuivirus rice hoja blanca virus (RHBV) has previously been shown to
represent the viral RNA interference (RNAi) suppressor and is active in both plant and insect cells
by binding short interfering RNAs (siRNAs) in vitro. Using a firefly luciferase-based silencing assay
it is described here that NS3 is also active in mammalian cells. This activity is independent of
the inducer molecule used. Using either synthetic siRNAs or a short hairpin RNA construct, NS3
was able to significantly suppress the RNAi-mediated silencing of luciferase expression in both
monkey (Vero) and human (HEK293) cells. These results support the proposed mode of action
of NS3 to act by sequestering siRNAs, the key molecules of the RNAi pathway conserved in
all eukaryotes. The possible applications of this protein in modulating RNAi and investigating the
proposed antiviral RNAi response in mammalian cell systems are discussed.
RNA interference (RNAi) is a conserved eukaryotic gene
regulation mechanism comprising endonucleoytic cleavage
of long double-stranded RNA (dsRNA) into short
interfering RNA (siRNA) molecules of 21–26 nt by an
enzyme designated Dicer (Bernstein et al., 2001). After
incorporation of the siRNAs in RNA-induced silencing
complexes (RISC), present in the cytoplasm, they are
unwound and the retained (guide) strand is used for
sequence-specific recognition and degradation of RNA
targets (reviewed by: Sontheimer, 2005). Although most
eukaryotes encode a functional RNAi pathway with
conserved parts, there are differences between the king-
doms (Dykxhoorn et al., 2003). Over time, different
biological processes involving this mechanism have been
identified (reviewed by: Herr, 2005; Sontheimer, 2005;
Tomari, 2005; Voinnet, 2005).
In plants, nematodes and insects, RNAi has been demon-
strated to serve as an innate antiviral defence response, but
RNAi has not been confirmed to operate as such in
mammalian cells (Li et al., 2002; Voinnet, 2001; Zambon
et al., 2006). To counteract this antiviral response, many
plant and insect viruses encode proteins that interfere with
the RNAi pathway. These proteins, denoted RNAi
suppressors, have been identified and characterized in
negative- and positive-stranded RNA viruses as well as
DNA viruses (reviewed by: Lecellier & Voinnet, 2004).
Similar to the RNAi suppressors of plant and insect viruses,
some proteins of human infecting viruses have also been
demonstrated to act like this. The NS1 protein of human
influenza A virus was shown to act as an RNAi suppressor
protein in plants and insect cells (Bucher et al., 2004; Li
et al., 2004). Next to the cross-kingdom activity by human
infecting viruses, some intraspecies RNAi suppression was
demonstrated, too. The human immunodeficiency virus
type 1 (HIV-1) Tat protein, for example, shows RNAi
suppression activity in cultured human cells (Bennasser
et al., 2005). A considerable number of viruses are able to
infect hosts belonging to two different kingdoms such as
plants and insects or insects and mammals. Rice hoja
blanca virus (RHBV; genus Tenuivirus) for example infects
rice and is propagatively transmitted by an insect vector,
the plant hopper Tagosodes orizicolus (Ramirez et al., 1993;
Ramirez et al., 1992). The virus has an ambisense RNA
genome which is divided among four segments (Fig. 1a).
As RHBV replication takes place in both plants and insects
(Falk & Tsai, 1998) it is likely to induce antiviral RNAi in
both.
We have previously identified the RNA 3-encoded NS3
protein (Fig. 1a) as an RNAi suppressor protein active in
plants (Bucher et al., 2003) and recently its RNAi
suppressor activity in cultured insect cells was established
(Hemmes et al., 2007). As NS3 has a high affinity for 21 nt
siRNAs (Hemmes et al., 2007), it is tempting to propose
that the protein acts by sequestering siRNAs. If this would
be the exclusive biochemical activity of NS3 to perform its
RNAi suppressor function it should also be operational in
mammalian cells.
To investigate this, a pEF5/V5-based expression plasmid
was constructed by fusing the NS3 gene to the maltose-
binding protein gene (yielding MBP2NS3) using
Invitrogen’s gateway technology. As negative controls,
pEF5/V5-based expression plasmids encoding the MBP
alone or fused to a mutant of the NS3 open reading frame
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(NS3m), in which three lysine residues, K173/K174/K175
were substituted with alanines, were constructed. NS3m
has a significantly decreased affinity for siRNA and shows
no RNAi suppressor activity in plants (H. Hemmes and
others, unpublished data). Vero cells were transfected with
the expression plasmids and 24 h post-transfection (p.t.)
the expression of MBP and MBP-tagged NS3 proteins was
verified by Western blotting (Fig. 1b).
Next a mammalian cell reporter gene RNAi assay was
developed based on firefly luciferase (Fluc). To this end,
Vero and HEK293 cells were co-transfected with plasmids
encoding Fluc and a short hairpin RNA (shRNA) construct
(Paddison et al., 2002) specifically targeting Fluc (shFluc)
or a scrambled shRNA. To ensure comparability, a Renilla
luciferase (Rluc) expression vector (pRL-CMV; Promega)
was used as the internal control. Luciferase expression
levels were determined 48 h p.t., using the Dual luciferase
assay (Promega). Cells co-transfected with Fluc- and
shFluc-encoding plasmids showed a drastic decrease in
Fluc expression levels, which was not observed in cells
expressing scrambled shRNA (Fig. 2a). This decrease was
dependent on the amount of the RNAi inducer (data not
shown) reaching a maximum silencing of approximately
80% of the original Fluc expression level. At this level, it
was not possible to further increase silencing of the Fluc
expression by adding more RNAi inducer plasmid.
To validate the assay, Vero cells were co-transfected with
Fluc, shFluc or a scrambled shRNA and the tombusvirus
P19 siRNA-binding RNAi suppressor-encoding plasmid,
known to be active in plant and mammalian cells (Dunoyer
et al., 2004; Lakatos et al., 2004). To observe the most
optimal RNAi suppression of P19, a sh-construct concen-
tration was chosen not over saturating the RNAi pathway
and giving a silencing of approximately 60% at 48 h p.t.
Using this set-up the observed luminescence in silenced
cells expressing P19 was significantly higher than in cells
expressing MBP, whereas non-silenced cells did not show
differences irrespective of the presence or absence of P19
(Fig. 2a).
These results demonstrate that the designed experimental
set-up can be used to determine RNAi suppressor activity
in mammalian cells. However, it should be noted that the
RNAi suppression conferred by the P19 protein was not as
high as previously reported in a different experimental
system (Dunoyer et al., 2004). We next tested the RNAi
suppressor activity of NS3 in Vero cells (Fig. 2b). Again a
significant and reproducible (partial) recovery of the
luminescence was observed in the presence of wild-type
NS3, either tagged or untagged, indicating that this protein
is able to suppress RNAi in mammalian cells, as was
observed previously in plant and insect cells (Hemmes
et al., 2007). The silenced cells transfected with NS3m
(expressed at a similar level as wild-type NS3; Fig. 2c)
showed no significant increase in luminescence. Using
HEK293 cells instead of Vero cells, similar results were
obtained for NS3 (Fig. 2b) and P19.
Instead of shRNAs, synthetic siRNAs are also used for
specific gene silencing in cultured mammalian cells
(Elbashir et al., 2001). Since Dicer action is most probably
not required for the activity of siRNAs, their use can give
more detailed information about the mode of action of
NS3 in the RNAi pathway. In the literature, siRNAs are
more potent RNAi inducers than shRNA constructs
(Paddison et al., 2002). Whereas shRNAs homologous to
Fluc yielded a maximal silencing effect of 80%, siRNAs
achieved over 95% of silencing (Fig. 3a). As expected, a
concentration-dependent decrease in the Fluc expression
was detected in cells transfected with Fluc plasmid DNA
and Fluc-specific siRNAs (siLuc) compared to cells
transfected with Fluc and the scrambled siRNAs (data
not shown).
Having demonstrated sequence-specific silencing using
synthetic siRNAs (Fig. 3a), timing of NS3 action was
investigated. As it proved impossible to suppress silencing
at the highest siRNAs concentrations, optimal conditions
for measuring RNAi suppression were determined. RNA
silencing was not suppressed in cells in which the NS3
plasmid was co-transfected with the Fluc plasmid and siLuc
(Fig. 3b). However, a significant increase in Fluc expression
was observed in cells initially transfected with the NS3
plasmid, and sequentially transfected after 24 h with Fluc
and siLuc (Fig. 3c).
Fig. 1. Schematic presentation of the RHBV genome and
transient expression of its NS3 protein. (a) The RHBV RNA
genome consists of a fully negative-stranded RNA 1 and 3
ambisense genome segments (RNA 2–4). (b) Expression in Vero
cells of MBP, MBP–NS3 or MBP–NS3 mutant (MBP–NS3m);
confirmed by Western blotting.
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This indicates that the NS3 protein needs to be present
prior to the accumulation of siRNAs as already reported
for the B2 RNAi suppressor of flock house virus in insect
cells (Li et al., 2004). It is apparent that NS3, due to its
higher affinity for double-stranded siRNA, may extract
siRNAs from the intermediate RISC complexes (R1 and
RLC), where the siRNAs are still double stranded.
However, single-stranded siRNAs present in mature, pre-
assembled RISC complexes cannot be dissociated by NS3;
consequently NS3 cannot compete for single-stranded
siRNA in these complexes (Hemmes et al., 2007).
Although, Dicer action is, most probably, not needed if
siRNAs are used as inducer molecules it cannot be ruled
out that NS3 acts by inhibition of Dicer needed in hairpin
transfections. Data obtained from the well established in
vitro Drosophila Dicer cleavage assay (Bernstein et al., 2001)
showed no inhibition of Dicer by the addition of the
bacterial produced MBP–NS3 protein, even at high
concentrations (Fig. 3d).
Altogether, these findings suggest that the siRNA-binding
capacity of NS3 is responsible for the observed RNAi
suppressor activity in mammalian cells. This is confirmed
by the observed decrease of the NS3 RNAi suppressor
activity by an increasing siRNA concentration, resulting in
a higher silencing signal. The combined presence of the
pre-transfected protein as well as the siRNA in one single
cell was investigated by cyto-immunological detection of
the protein and transfection of rhodamine-labelled siRNA.
This revealed exclusively doubly transfected cells at a
transfection efficiency of approximately 60%.
Taken together, our data suggest that the RNAi suppressor
activity of NS3 in mammalian cells is strongly dependent
on the high affinity for 21 nt dsRNA, but independent of
the used inducer molecules. Furthermore, the NS3 RNAi
suppressor activity is not restricted to plant and insect cells,
but is extended to mammalian cells. The majority of RNAi
suppressors studied so far bind either long or short dsRNA
(Lakatos et al., 2006; Merai et al., 2006), representing
conserved molecules of the RNAi pathway in all eukaryotic
organisms.
Incapacitating such essential molecules within the RNAi
pathway offers a suppressor protein the possibility to be
active in different host organisms and reduces the chance
of these different hosts to evade the RNAi suppression. On
the other hand, it implies that relatively high amounts of
RNAi suppressors are needed in the cytoplasm of cells to
reach a good level of suppression when compared with a
presumed suppressor protein that would inhibit specific
proteins of the RNAi machinery. Alterations in the host
protein that interacts with the latter type of RNAi
suppressor, though, may easily result in loss of RNAi
suppression and hence avirulence. Regarding the fact that
RHBV is facing antiviral RNAi in both plant and insect
hosts, it is not surprising that NS3 interferes with the
shared part of the RNAi pathways and not with a specific
protein of one host. This hypothesis is in line with the
Fig. 2. Effect of NS3 expression on shRNA-induced silencing. HEK293 (dashed, panel b) or Vero (solid) cells were co-
transfected with Fluc, a non-specific (sh-scrambled) or specific (shFluc) Fluc shRNA, and either MBP or P19 (a), MBP–NS3
mutant (NS3m) or NS3 (b), either MBP-tagged or untagged (*). Each treatment was performed in duplicate in at least two
independent assays and the Fluc activity was normalized to Rluc for each of these treatments. (c) Western blotting confirmed
expression of NS3 constructs. Immunological detection of b-actin served as loading control.
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observation that the NS3 RNAi suppressor activity is also
exhibited in mammalian cells. As the effects of synthetic
siRNAs and a shRNA construct were similar, it is tempting
to assume that NS3 acts downstream of both RNAi inducer
molecules or on the inducer molecule itself. This is in line
with our model where NS3 captures and sequesters siRNA
(Hemmes et al., 2007).
Using plant, insect or mammalian cell-based assays, a
number of innate immunity suppressors, like interferon
antagonists, encoded by mammalian viruses have been
demonstrated to have RNAi suppressor activity. Some of
the best studied examples so far are NS1 of influenza A
virus (Bucher et al., 2004; Li et al., 2004), VP35 of Ebola
virus, E3L of vaccinia virus, Tat of HIV-1, NSs of La Crosse
virus, Tas of primate foamy virus-1 and C of hepatitis virus
C (Haasnoot et al., 2007; Schutz & Sarnow, 2006; Soldan
et al., 2005). Furthermore, it has been shown that the
interferon antagonists VP35, NS1 and E3L are RNAi
suppressors in human cells that are capable of restoring the
production of a HIV-1 strain defective in the Tat gene
(Haasnoot et al., 2007).
These results indicate that RNAi, like the interferon
pathway, may be an important innate antiviral defence
response in mammals, and that mammalian viruses, similar
to plant and insect viruses, need to counteract this response
in order to replicate. Although not studied in great detail,
the RNAi suppressors from mammalian viruses seem to
bind longer dsRNAs with a higher affinity than siRNAs.
Besides serving as RNAi inducers, long cytoplasmic
dsRNAs induce the replication-dependent antiviral inter-
feron pathway in mammalian cells (Kato et al., 2005;
Marques et al., 2006). It is therefore difficult to separate
these two pathways as well as to unravel the effect of long
dsRNA-binding proteins with respect to both pathways.
However, using a protein, like NS3, exclusively binding
siRNA, provides a promising strategy to study the possible
presence of an antiviral RNAi pathway in mammalian cells.
The use of NS3 could also give information about the
relative importance of each antiviral pathway, by deter-
mining its complementing effect on replication level of
viruses defective in their innate antiviral suppressor
protein.
Next to the possibility to reveal novel aspects of the virus–
host interaction, the in trans complementation of viruses
defective in their own innate antiviral suppressor genes
opens the chance of virus particle production in plants,
mammalian and insect cells, for example, for attenuated
Fig. 3. (a) siRNA- or shRNA-based silencing in Vero cells co-transfected with either specific (luc) or unspecific (scrambled)
RNAi inducer, together with Fluc and Rluc plasmids. (b) Effect of co-transfected NS3. Vero cells were co-transfected with
vectors encoding Fluc, Rluc and either MBP or MBP–NS3 as well as siRNA specific (siLuc) or unspecific (si-scrambled) for
Fluc. (c) Effect of 24 h pre-transfected NS3. Vero cells were transfected with Fluc and Rluc expression vectors, together with
siRNA either specific against Fluc (siLuc) or unspecific (si-scrambled). Fluc activity was normalized to Rluc activity
independently for each treatment. The resulted relative luciferase activity is a representative of at least two independent assays,
whereas each assay was performed in duplicate. (d) Effect of NS3 on Dicer activity in vitro. Radioactively labelled dsRNA (lane
7) was cleaved into siRNA (lane 8) in Drosophila embryo extract in the absence (lane 6) or increasing presence of bacterial
purified MBP–NS3 protein (lanes 1–5).
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vaccine strains. Until now, a problem faced during the
production cycle of attenuated viruses, most probably
having defects in their innate antiviral suppressor genes, are
the low virus titres reached in culture. In insect cells it was
shown that virus titres can be increased by complementa-
tion, using either the virus’ own suppressor protein or even
cross-kingdom suppressor proteins (Li et al., 2004). Recent
results have shown that this is also possible by using cell
lines stably expressing an RNAi suppressor protein, such as
Tat of HIV-1. The main drawback of using mammalian-
encoded RNAi suppressors, like VP35 and NS1, may in this
case be the risk of wild-type rescuing due to recombina-
tion. The use of the NS3-based producer cell lines would
avoid such drawbacks and improve the biosafety of such an
approach. Further research is needed to confirm the
potential application of NS3 in mammalian virus research
and production strategies.
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